<VariationArchive VariationID="1460077" VariationName="NC_000023.10:g.(?_99551275)_(99605722_?)del" VariationType="Deletion" Accession="VCV001460077" Version="8" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1481434" VariationID="1460077">
      <GeneList>
        <Gene Symbol="PCDH19" FullName="protocadherin 19" GeneID="57526" HGNC_ID="HGNC:14270" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="100291644" stop="100410273" display_start="100291644" display_stop="100410273" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="99546641" stop="99665270" display_start="99546641" display_stop="99665270" Strand="-" />
          </Location>
          <OMIM>300460</OMIM>
          <Haploinsufficiency last_evaluated="2023-02-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PCDH19">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-02-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PCDH19">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000023.10:g.(?_99551275)_(99605722_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" innerStart="99551275" innerStop="99605722" display_start="99551275" display_stop="99605722" variantLength="54448" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.(?_99551275)_(99605722_?)del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.(?_99551275)_(99605722_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000023.10:g.(?_99551275)_(99605722_?)del AND Developmental and epileptic encephalopathy, 9" Accession="RCV001951412" Version="7">
        <ClassifiedConditionList TraitSetID="3055">
          <ClassifiedCondition DB="MedGen" ID="C1848137">Developmental and epileptic encephalopathy, 9</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-22" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">30828795</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3055" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5029" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">EPILEPSY, FEMALE-RESTRICTED, WITH MENTAL RETARDATION</ElementValue>
                <XRef Type="MIM" ID="300088" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 9</ElementValue>
                <XRef ID="MONDO:0010246" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Early infantile epileptic encephalopathy 9</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">JUBERG-HELLMAN SYNDROME</ElementValue>
                <XRef Type="MIM" ID="300088" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PCDH19-Related X-Linked Female-Limited Epilepsy with Mental Retardation</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EFMR</ElementValue>
                <XRef Type="MIM" ID="300088" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DEE9</ElementValue>
                <XRef Type="MIM" ID="300088" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000509008" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520998" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000519196" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520051" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520979" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520980" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520996" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000527938" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520995" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000519167" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551668" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10806" />
                <XRef ID="10806" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="101039" DB="Orphanet" />
              <XRef ID="2076" DB="Orphanet" />
              <XRef ID="C1848137" DB="MedGen" />
              <XRef ID="MONDO:0010246" DB="MONDO" />
              <XRef Type="MIM" ID="300088" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4262079" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="NM_001184880.1_X_Deletion (exons 4-6)|MedGen:C1848137" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002241018" DateUpdated="2024-06-09" DateCreated="2022-03-28" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30828795</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 4-6 of the PCDH19 gene, which includes the termination codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to alter mRNA translation or result in a truncated protein product. This variant has not been reported in the literature in individuals affected with PCDH19-related conditions. The region of the PCDH19 gene that includes exon(s) 6 has been determined to be clinically significant (PMID: 30828795; Invitae). Therefore, deletions that encompass that region are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PCDH19" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_99551275)_(99605722_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1848137" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4262079" TraitType="Disease" MappingType="XRef" MappingValue="C1848137" MappingRef="MedGen">
        <MedGen CUI="C1848137" Name="Developmental and epileptic encephalopathy, 9" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

